Company Filing History:
Years Active: 2015
Title: Annelie Schairer: Innovator in Cancer Research
Introduction
Annelie Schairer is a prominent inventor based in Escondido, California. She has made significant contributions to the field of cancer research, particularly in understanding cancer stem cells and their self-renewal potential. Her innovative work has the potential to impact cancer diagnostics and treatment strategies.
Latest Patents
Annelie Schairer holds a patent titled "Compositions and methods for determining cancer stem cell self-renewal potential." This invention provides compositions and methods for determining the self-renewal potential of cancer stem cells (CSCs) through the analysis of the cross-talk between cell self-renewal pathways. The patent also addresses the prediction of drug susceptibility of CSCs and the progression of cancer corresponding to these cells. The method involves detecting and quantifying various B-cell lymphoma-2 (Bcl-2) family protein isoforms or transcripts in CSCs. Additionally, it includes methods to measure levels of Wnt, glycogen synthase kinase-3 beta (GSK-3 beta), glycogen synthase kinase-3 alpha (GSK-3 alpha), and Sonic Hedgehog Homolog (SHH) family proteins for diagnostic and prognostic purposes.
Career Highlights
Annelie Schairer is affiliated with the University of California, where she continues her research and innovation in cancer biology. Her work has garnered attention for its potential applications in drug discovery and cancer treatment.
Collaborations
Annelie has collaborated with notable colleagues, including Catriona Jamieson and Ifat Geron, to advance her research in cancer stem cell biology.
Conclusion
Annelie Schairer is a dedicated inventor whose work in cancer research is paving the way for new diagnostic and therapeutic approaches. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire advancements in the field.